Center-Authored Papers

Filters: Author is Greenberg, P D  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Y
Yee C, Greenberg P.  2002.  Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses.. Nature reviews. Cancer. 2(6):409-19.
Yee C, Gilbert MJ, Riddell SR, Brichard VG, Fefer A, Thompson JA, Boon T, Greenberg PD.  1996.  Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus.. Journal of immunology (Baltimore, Md. : 1950). 157(9):4079-86. Abstract
Yee C, Savage PA, Lee PP, Davis MM, Greenberg PD.  1999.  Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.. Journal of immunology (Baltimore, Md. : 1950). 162(4):2227-34. Abstract
Yee C, Thompson JA, Byrd D, Riddell SR, Roche P, Celis E, Greenberg PD.  2002.  Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells.. Proceedings of the National Academy of Sciences of the United States of America. 99(25):16168-73. Abstract
W
Wölfl M, Rutebemberwa A, Mosbruger T, Mao Q, Li H-mei, Netski D, Ray SC, Pardoll D, Sidney J, Sette A et al..  2008.  Hepatitis C virus immune escape via exploitation of a hole in the T cell repertoire.. Journal of immunology (Baltimore, Md. : 1950). 181(9):6435-46. Abstract
Wölfl M, Greenberg PD.  2014.  Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8(+) T cells.. Nature protocols. 9(4):950-66. Abstract
Wang J, Press OW, Lindgren CG, Greenberg P, Riddell S, Qian X, Laugen C, Raubitschek A, Forman SJ, Jensen MC.  2004.  Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8+ cytotoxic T lymphocytes.. Molecular therapy : the journal of the American Society of Gene Therapy. 9(4):577-86. Abstract
Wang J, Jensen M, Lin Y, Sui X, Chen E, Lindgren CG, Till B, Raubitschek A, Forman SJ, Qian X et al..  2007.  Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains.. Human gene therapy. 18(8):712-25. Abstract
T
Till BG, Jensen MC, Wang J, Chen EY, Wood BL, Greisman HA, Qian X, James SE, Raubitschek A, Forman SJ et al..  2008.  Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells.. Blood. 112(6):2261-71. Abstract
Till BG, Jensen MC, Wang J, Qian X, Gopal AK, Maloney DG, Lindgren CG, Lin Y, Pagel JM, Budde LE et al..  2012.  CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results.. Blood. 119(17):3940-50. Abstract
Teague RM, Greenberg PD, Fowler C, Huang MZ, Tan X, Morimoto J, Dossett ML, Huseby ES, Ohlén C.  2008.  Peripheral CD8+ T cell tolerance to self-proteins is regulated proximally at the T cell receptor.. Immunity. 28(5):662-74. Abstract
Tan X, Sande JL, Pufnock JS, Blattman JN, Greenberg PD.  2011.  Retinoic acid as a vaccine adjuvant enhances CD8+ T cell response and mucosal protection from viral challenge.. Journal of virology. 85(16):8316-27. Abstract
S
Stromnes IM, Greenberg PD.  2016.  Pancreatic Cancer: Planning Ahead for Metastatic Spread.. Cancer cell. 29(6):774-6. Abstract
Stromnes IM, Hulbert A, Pierce RH, Greenberg PD, Hingorani SR.  2017.  T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma.. Cancer immunology research. 5(11):978-991. Abstract
Stromnes IM, Schmitt TM, Chapuis AG, Hingorani SR, Greenberg PD.  2014.  Re-adapting T cells for cancer therapy: from mouse models to clinical trials.. Immunological reviews. 257(1):145-64. Abstract
Stromnes IM, DelGiorno KE, Greenberg PD, Hingorani SR.  2014.  Stromal re-engineering to treat pancreas cancer.. Carcinogenesis. 35(7):1451-60. Abstract
Stromnes IM, Brockenbrough SJ, Izeradjene K, Carlson MA, Cuevas C, Simmons RM, Greenberg PD, Hingorani SR.  2014.  Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity.. Gut. 63(11):1769-81. Abstract
Stromnes IM, Fowler C, Casamina CC, Georgopolos CM, McAfee MS, Schmitt TM, Tan X, Kim T-D, Choi I, Blattman JN et al..  2012.  Abrogation of SRC homology region 2 domain-containing phosphatase 1 in tumor-specific T cells improves efficacy of adoptive immunotherapy by enhancing the effector function and accumulation of short-lived effector T cells in vivo.. Journal of immunology (Baltimore, Md. : 1950). 189(4):1812-25. Abstract
Stromnes IM, Blattman JN, Tan X, Jeevanjee S, Gu H, Greenberg PD.  2010.  Abrogating Cbl-b in effector CD8(+) T cells improves the efficacy of adoptive therapy of leukemia in mice.. The Journal of clinical investigation. 120(10):3722-34. Abstract
Stromnes IM, Greenberg PD, Hingorani SR.  2014.  Molecular Pathways: Myeloid Complicity in Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 20(20):5157-70. Abstract
Stromnes IM, Schmitt TM, Hulbert A, Brockenbrough SJ, Nguyen HN, Cuevas C, Dotson AM, Tan X, Hotes JL, Greenberg PD et al..  2015.  T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma.. Cancer cell. 28(5):638-52. Abstract
Schreiber H, Greenberg P.  2015.  Editorial overview: Tumour immunology.. Current opinion in immunology. 33:ix-xi.
Schmitt TM, Stromnes IM, Chapuis AG, Greenberg PD.  2015.  New Strategies in Engineering T-cell Receptor Gene-Modified T Cells to More Effectively Target Malignancies.. Clinical cancer research : an official journal of the American Association for Cancer Research. 21(23):5191-5197. Abstract
Schmitt TM, Aggen DH, Stromnes IM, Dossett ML, Richman SA, Kranz DM, Greenberg PD.  2013.  Enhanced-affinity murine TCRs for tumor/self-antigens can be safe in gene therapy despite surpassing the threshold for thymic selection.. Blood. 122(3):348-56. Abstract
Schmitt TM, Ragnarsson GB, Greenberg PD.  2009.  T cell receptor gene therapy for cancer.. Human gene therapy. 20(11):1240-8. Abstract